On a weekend during which 257 players will find their first NFL home, linebacker Dee Winters was sent to his second. The Dallas Cowboys acquired Winters from the San Francisco 49ers in exchange for a ...

1000-Lb. Sisters star Amy Lovvorn (née Slaton) has a whole new look — literally and figuratively. Lovvorn, 38, showed off the results of her eye surgery in a TikTok clip posted in July 2025, prior to ...

The 202-pound Burmese python was caught by Florida resident Carl Jackson Miami Herald/Tribune News Service via Getty Florida resident Carl Jackson caught the second-heaviest invasive Burmese python ...

Jackson caught the 202-pound snake with the help of his wife, adopted son, and step-daughter Jackson works for the Florida Fish and Wildlife Conservation Commission (FWC) to prevent pythons from ...

Carl Jackson didn't expect such massive results when he set out to hunt pythons with his family on Tuesday, Jan. 13. He was retracing his tracks at Big Cypress National Preserve outside of Naples, ...

“My 600-lb Life” star Charity Pierce has died. She was 50. Pierce was in hospice care for at least a month before her death on Tuesday due to ongoing medical conditions, including lymphedema and fluid ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

“1000-lb Sisters” fans have been watching Tammy and Amy Slaton’s journey for years, but is the TLC reality series coming to an end? The “1000-lb Sisters” season 7 finale aired in June, and season 8 ...

A massive 215-pound Burmese python the largest ever recorded in Florida was discovered in the heart of the Everglades, stunning wildlife experts and conservationists alike. This video explores the ...

LB Pharmaceuticals’ final haul could increase by around $42.7 million if underwriters take up their 30-day option to buy an additional 2.85 million shares. (Yelena Rodriguez Mena/iStock/Getty Images ...

Proceeds from an IPO are expected to fund a phase 3 study of LB Pharmaceuticals' LB-102 in schizophrenia, plus a phase 2 trial in bipolar disorder. (iStock / Getty Images Plus) Despite the stagnant ...